Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Scripps-eMed Covid-19 Study: A Prospective Monitoring Study for Those Individuals Treated With Paxlovid

NCT05618600 is registered in ClinicalTrials.gov with Scripps Translational Science Institute as lead sponsor.

NCT NCT05618600
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05618600 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Scripps-eMed Covid-19 Study: A Prospective Monitoring Study for Those Individuals Treated With Paxlovid
Lead sponsor
Scripps Translational Science Institute
Phase
Observational
Overall status
Completed
Start date
August 4, 2022
Completion date
June 10, 2024
Enrollment
917 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19